2019
Decreased immune response after PASylation of stealth ferritin nanocarriers
TESAROVA, B, H POLANSKA, V SMIDOVA a Zita GOLIÁŠOVÁZákladní údaje
Originální název
Decreased immune response after PASylation of stealth ferritin nanocarriers
Autoři
TESAROVA, B, H POLANSKA, V SMIDOVA a Zita GOLIÁŠOVÁ
Vydání
MENDELNET 2019: PROCEEDINGS OF 26TH INTERNATIONAL PHD STUDENTS CONFERENCE, 2019
Další údaje
Jazyk
angličtina
Typ výsledku
Prezentace na konferencích
Utajení
není předmětem státního či obchodního tajemství
ISBN
978-80-7509-688-3
UT WoS
000576735500121
Klíčová slova anglicky
apoferritin; immune response; nanomedicine; PASylation
Změněno: 1. 11. 2021 14:19, Mgr. Zita Goliášová
Anotace
V originále
The effects on immunocompatibility after performed surface modifications (PEGylation and PASylation) of natural nanocarriers based on ferritin (FRT) were tested in this work. Potential cytostatic drug ellipticine (Elli) was encapsulated into FRT, leading to formation of FRTElli. The main goals of prepared PEG-FRTElli, PAS-10-FRTElli and PAS-20-FRTElli were to achieve decreased in vitro macrophage uptake and decreased in vivo complement activation. Macrophage uptake was studied via flow cytometry and complement activation via western blot. According to performed experiments PAS-10 modification was the only one that was sufficient to ensure both aspects.